Invention Grant
- Patent Title: Pyrimidooxazocine derivatives as mTOR-inhibitors
- Patent Title (中): 嘧啶并恶嗪酸衍生物作为mTOR-抑制剂
-
Application No.: US14374838Application Date: 2013-01-25
-
Publication No.: US09120812B2Publication Date: 2015-09-01
- Inventor: Alain Braun , Olivier Crespin , Yann Foricher , Gilbert Marciniak , Nicolas Muzet , Eric Nicolai , Cecile Pascal , Bertrand Vivet , Fabrice Viviani
- Applicant: SANOFI
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: FR1250768 20120126
- International Application: PCT/IB2013/050656 WO 20130125
- International Announcement: WO2013/111106 WO 20130801
- Main IPC: C07D498/04
- IPC: C07D498/04 ; C07D519/00
Abstract:
The invention relates to bicyclic heterocyclic derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.
Public/Granted literature
- US20140378433A1 PYRIMIDOOXAZOCINE DERIVATIVES AS MTOR - INHIBITORS Public/Granted day:2014-12-25
Information query
